At the time of writing, Sionna Therapeutics Inc [SION] stock is trading at $32.72, up 5.86%. An important factor to consider is whether the stock is rising or falling in short-term value. The SION shares have gain 15.41% over the last week, with a monthly amount glided 47.25%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Sionna Therapeutics Inc [NASDAQ: SION] stock has seen the most recent analyst activity on September 03, 2025, when RBC Capital Mkts initiated its Sector Perform rating and assigned the stock a price target of $22. Previously, Raymond James started tracking the stock with Strong Buy rating on September 03, 2025, and set its price target to $45. On March 04, 2025, TD Cowen initiated with a Buy rating. Stifel started tracking the stock assigning a Buy rating and suggested a price target of $32 on March 04, 2025. Guggenheim initiated its recommendation with a Buy and recommended $45 as its price target on March 04, 2025.
For the past year, the stock price of Sionna Therapeutics Inc fluctuated between $7.26 and $31.47. Currently, Wall Street analysts expect the stock to reach $33.5 within the next 12 months. Sionna Therapeutics Inc [NASDAQ: SION] shares were valued at $32.72 at the most recent close of the market. An investor can expect a potential return of 2.38% based on the average SION price forecast.
Analyzing the SION fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.17, Equity is -0.63 and Total Capital is -0.21. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 30.14 points at the first support level, and at 27.56 for the second support level. However, for the 1st resistance point, the stock is sitting at 34.65, and for the 2nd resistance point, it is at 36.58.
Ratios To Look Out For
It is important to note that Sionna Therapeutics Inc [NASDAQ:SION] has a current ratio of 35.33. On the other hand, the Quick Ratio is 35.33, and the Cash Ratio is 5.43.
Transactions by insiders
Recent insider trading involved Atlas Venture Fund XI, LP, Shareholder, that happened on Oct 16 ’25 when 0.14 million shares were purchased. Shareholder, Atlas Venture Opportunity Fund completed a deal on Oct 16 ’25 to buy 29363.0 shares. Meanwhile, Director MICHAEL CLOONAN bought 200.0 shares on Oct 16 ’25.
